Launch of EliA Symphony-s

Products are for professional/laboratory use only.

Abacus dx is happy to announce the launch of the new EliA Symphony^S test.

The EliA Symphony^S (S stands for “Sensitive”) is designed for high clinical accuracy to assist in the diagnosis for connective tissue disease (CTD) and to differentiate between CTD and non-CTD patients.

The benefits of the newly improved EliA Symphony^S include:

• Use of new recombinant antigens and coating methods to improve detection of autoantibodies including U1RNP (RNP70, A, C), SS-A/Ro (60 kDa, 52 kDa), SS-B/La, Centromere B, Scl-70, Jo-1, synthetic SmD3 peptide (see Table 2 in attached brochure)
• Enhanced antigen presentation resulting in improved accessibility of epitopes and therefore higher sensitivity and specificity compared to the current EliA Symphony
• Use of IgG Calibrators standardised against WHO International Reference Preparation (IRP) 67/86.3.

The new EliA Symphony^S is now available from Abacus dx

• EliA Symphony^S (PU14567101) will replace the current EliA Symphony test (PU14550801)
• For evaluation purposes the current EliA Symphony test will be available in parallel for a period of 18 months, i.e. June 2019.

Go Back